NO20014261L - Histidinproteinfosfatase - Google Patents

Histidinproteinfosfatase

Info

Publication number
NO20014261L
NO20014261L NO20014261A NO20014261A NO20014261L NO 20014261 L NO20014261 L NO 20014261L NO 20014261 A NO20014261 A NO 20014261A NO 20014261 A NO20014261 A NO 20014261A NO 20014261 L NO20014261 L NO 20014261L
Authority
NO
Norway
Prior art keywords
enzyme
phosphatase
relates
proteins
administered
Prior art date
Application number
NO20014261A
Other languages
English (en)
Other versions
NO20014261D0 (no
Inventor
Susanne Klumpp
Roland Kellner
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20014261D0 publication Critical patent/NO20014261D0/no
Publication of NO20014261L publication Critical patent/NO20014261L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Oppfinnelsen vedrører et nytt enzym, histidinproteinfosfatase, som er utvunnet fra pattedyrkilder, og dets homologvarianter. Oppfinnelsen vedrører videre DNA-sekvenser som koder for proteinene, en fremgangs-måte for fremstilling av de sist-nevnte, og antistoffer rettet mot dem. Den nye fosfatase kan anvendes til diagnose av patologiske til-stander av celleregulering og celle-vekst, og som farmasøytisk legemiddel som kan administreres i forbindelse med patologiske forstyrrelser rela-tert til målfunksjoner av enzymet.
NO20014261A 1999-03-04 2001-09-03 Histidinproteinfosfatase NO20014261L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19909388 1999-03-04
PCT/EP2000/001774 WO2000052175A1 (en) 1999-03-04 2000-03-02 Histidine protein-phosphatase

Publications (2)

Publication Number Publication Date
NO20014261D0 NO20014261D0 (no) 2001-09-03
NO20014261L true NO20014261L (no) 2001-09-03

Family

ID=7899608

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014261A NO20014261L (no) 1999-03-04 2001-09-03 Histidinproteinfosfatase

Country Status (22)

Country Link
US (1) US6812015B1 (no)
EP (1) EP1159430B1 (no)
JP (1) JP2002537814A (no)
KR (1) KR20020002400A (no)
CN (1) CN1201009C (no)
AR (1) AR022836A1 (no)
AT (1) ATE393827T1 (no)
AU (1) AU762809B2 (no)
BR (1) BR0008607A (no)
CA (1) CA2364495A1 (no)
CZ (1) CZ20013172A3 (no)
DE (1) DE60038731T2 (no)
ES (1) ES2303813T3 (no)
HK (1) HK1042729A1 (no)
HU (1) HUP0200241A2 (no)
MX (1) MXPA01008941A (no)
NO (1) NO20014261L (no)
PL (1) PL350323A1 (no)
RU (1) RU2281973C2 (no)
SK (1) SK12242001A3 (no)
WO (1) WO2000052175A1 (no)
ZA (1) ZA200108129B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1363941A2 (en) * 2001-02-16 2003-11-26 MERCK PATENT GmbH Histidine phosphatase interacting protein of 120 kd
WO2002070676A2 (en) * 2001-03-08 2002-09-12 Merck Patent Gmbh Use of protein histidine phosphatase
ES2254977T3 (es) * 2002-11-09 2006-06-16 Merck Patent Gmbh Ensayo de fosfomidasas.
US9052304B2 (en) 2009-03-13 2015-06-09 Terrasep, Llc Methods and apparatus for centrifugal liquid chromatography

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19811194A1 (de) * 1998-03-10 1999-09-16 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Prostatagewebe

Also Published As

Publication number Publication date
AR022836A1 (es) 2002-09-04
ATE393827T1 (de) 2008-05-15
AU3808000A (en) 2000-09-21
ES2303813T3 (es) 2008-09-01
DE60038731T2 (de) 2009-07-02
BR0008607A (pt) 2002-01-02
NO20014261D0 (no) 2001-09-03
EP1159430B1 (en) 2008-04-30
AU762809B2 (en) 2003-07-03
PL350323A1 (en) 2002-12-02
DE60038731D1 (de) 2008-06-12
US6812015B1 (en) 2004-11-02
CZ20013172A3 (cs) 2001-12-12
CN1342205A (zh) 2002-03-27
RU2281973C2 (ru) 2006-08-20
CA2364495A1 (en) 2000-09-08
ZA200108129B (en) 2003-03-26
EP1159430A1 (en) 2001-12-05
HK1042729A1 (zh) 2002-08-23
SK12242001A3 (sk) 2002-06-04
CN1201009C (zh) 2005-05-11
JP2002537814A (ja) 2002-11-12
KR20020002400A (ko) 2002-01-09
HUP0200241A2 (hu) 2002-05-29
MXPA01008941A (es) 2002-06-26
WO2000052175A1 (en) 2000-09-08

Similar Documents

Publication Publication Date Title
US10703789B2 (en) Modified polynucleotides for the production of secreted proteins
JP6946384B2 (ja) 脂質ナノ粒子を含む医薬組成物
Liao et al. IL‐17 alters the mesenchymal stem cell niche towards osteogenesis in cooperation with osteocytes
US9878056B2 (en) Modified polynucleotides for the production of cosmetic proteins and peptides
MA31077B1 (fr) Polypeptides heterologues il-17a/f et utilisation des polypeptides a des fins therapeutiques
JP2018075011A (ja) クロストリジウム・ヒストリチクム（ｃｌｏｓｔｒｉｄｉｕｍ ｈｉｓｔｏｌｙｔｉｃｕｍ）酵素およびその使用のための方法
RU2008146991A (ru) Способ индукции дифференциации плюрипотентных стволовых клеток в кардиомиоциты
EA200970263A1 (ru) Полностью человеческая высокопродуктивная система получения усовершенствованных антител и белков
Huo et al. Chrysin induces osteogenic differentiation of human dental pulp stem cells
US20180360995A1 (en) Modified polynucleotides for the production of cosmetic proteins and peptides
EP0232523A3 (en) Dna sequences which encode for proteins with the biological activity of husi-type i inhibitors, their production by gene technology and drugs containing these proteins
NO20014261L (no) Histidinproteinfosfatase
KR20130108317A (ko) Rna 리가제로서 hspc117 분자의 용도
DK1639119T3 (da) Fremgangsmåde til mikrobiologisk isomerisering af alpha-hydroxycarboxylsyrer
KR20140095295A (ko) 재조합 상아질 인산단백질을 포함하는 치수 세포의 부착 또는 증식 촉진용 조성물
EP2128172A1 (en) Preparation process of recombinant human p43 protein
Wang Amino acid racemase responsible for the biosynthesis of D-aspartate and D-serine signaling molecules in Aplysia californica central nervous system
Kramhøft et al. The role of low molecular weight peptides in the regulation of RNA synthesis in Schizosaccharomyces pombe

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application